Breast cancer risk estimates for relatives of white and African American women with breast cancer in the women's contraceptive and reproductive experiences study

TY - JOUR

T1 - Breast cancer risk estimates for relatives of white and African American women with breast cancer in the women's contraceptive and reproductive experiences study

AU - Simon, Michael S.

AU - Korczak, Jeannette F.

AU - Yee, Cecilia L.

AU - Malone, Kathleen E.

AU - Ursin, Giske

AU - Bernstein, Leslie

AU - McDonald, Jill A.

AU - Deapen, Dennis

AU - Strom, Brian L.

AU - Press, Michael F.

AU - Marchbanks, Polly A.

AU - Burkman, Ronald T.

AU - Weiss, Linda K.

AU - Schwartz, Ann G.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Purpose: Family history is a well-recognized risk factor for breast cancer. Familial aggregation and segregation analyses have estimated breast cancer risk based on family history primarily for white women; such information is limited for African American (AA) women. The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women. Methods: We used family cancer history from 2,676 white and 1,525 AA women with breast cancer (probands) in the population-based National Institute of Child Health and Human Development's Women's Contraceptive and Reproductive Experiences (CARE) Study to estimate age-specific breast cancer risks in their first degree adult female relatives. Cumulative hazard curves were calculated for relatives of all probands using Cox proportional hazards models, and were stratified by the proband's race and age at diagnosis and number of relatives affected. Results: Breast cancer risks for white and AA women with a family history of the disease are similar through age 49 years, but diverge afterwards, with higher risks by age 79 in white women than in AA women (17.5% [SE, 0.9%] v 12.2% [SE, 1.1%]; P < .001). These risks increase as the number of affected first degree relatives increases, reaching 25.2% (SE, 3.4%) and 16.9% (SE, 4.0%) in white and AA women with more than one affected relative, respectively (P = .3). Conclusion: We found age-related racial differences in breast cancer risk in women with a family history of breast cancer and have updated risk estimates for white and AA women for clinical use.

AB - Purpose: Family history is a well-recognized risk factor for breast cancer. Familial aggregation and segregation analyses have estimated breast cancer risk based on family history primarily for white women; such information is limited for African American (AA) women. The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women. Methods: We used family cancer history from 2,676 white and 1,525 AA women with breast cancer (probands) in the population-based National Institute of Child Health and Human Development's Women's Contraceptive and Reproductive Experiences (CARE) Study to estimate age-specific breast cancer risks in their first degree adult female relatives. Cumulative hazard curves were calculated for relatives of all probands using Cox proportional hazards models, and were stratified by the proband's race and age at diagnosis and number of relatives affected. Results: Breast cancer risks for white and AA women with a family history of the disease are similar through age 49 years, but diverge afterwards, with higher risks by age 79 in white women than in AA women (17.5% [SE, 0.9%] v 12.2% [SE, 1.1%]; P < .001). These risks increase as the number of affected first degree relatives increases, reaching 25.2% (SE, 3.4%) and 16.9% (SE, 4.0%) in white and AA women with more than one affected relative, respectively (P = .3). Conclusion: We found age-related racial differences in breast cancer risk in women with a family history of breast cancer and have updated risk estimates for white and AA women for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=33745004424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745004424&partnerID=8YFLogxK

U2 - https://doi.org/10.1200/JCO.2005.04.1087

DO - https://doi.org/10.1200/JCO.2005.04.1087

M3 - Article

C2 - 16735703

SN - 0732-183X

VL - 24

SP - 2498

EP - 2504

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -